Search
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications.
It looks at how OST medications are...
Responding to drugs and homelessness. Innovative approaches in Europe
Objective: To explore innovative programmes providing solutions in the field of homelessness and drugs.
Background: The association between long-term homelessness, problem drug use and alcohol dependence are well documented. Evidence...
A Covid-19 Coping Toolkit for Parents and Caregivers in Recovery
This booklet is intended for a global audience of parents and caregivers who are in all stages of recovery from substance use disorders during the COVID-19 pandemic.
The main feature of this booklet includes seven tip-sheets that offer...
#Tamojunto 2.0 program helps reduce the onset of alcohol use by adolescents
A study by Unifesp identified that the Ministry of Health's school prevention program reduces the initiation of alcohol use by adolescents.
Adolescents who participated in the program's classes were 22% less likely to initiate alcohol use...
State of the Sector 2019: Drug and Alcohol Family Support
This report shares the findings from Adfam's State of the Sector Family Support Survey which in 2019 asked 117 practitioners and managers working in family support services in England about current trends, developments, strengths and...
Supporting Parents Affected by Child-parent Abuse (CPA) from Substance-using Children
Adfam has produced an online toolkit for practitioners working with parents who care for someone who uses drugs or alcohol and is also abusive toward them.
The toolkit contains resources for practitioners to work through with their clients...
Fighting Their Own Battle: Families of Veterans with Substance Use Problem
Adfam, in collaboration with the University of York, and funded by the Forces in Mind Trust, has published a research report outlining the experiences and needs of families of veterans with substance use problems (FVSUs), along with a new...
Families, substance use and mental health: Report and Toolkit
Dual diagnosis is the term used to describe people with mental health problems, who also misuse drugs or alcohol.
People affected by dual diagnosis often fall through the cracks of public services, and so do their families. Those cracks...
The Science of Physical Activity
What is the science behind it?
-
Physical activity has many health benefits: it strengthens the heart and can help improve bone health and fitness, lowers blood pressure, improves sleep quality and reduces the risk of diabetes.
-
Phys...
Addiction and the Family International Network
The AFINet Webinars cover a range of topics related to Addiction and the Family. The programme for 2021 is below. Participation in each webinar is free, but to join, you MUST register beforehand. For each Webinar that you are interested in...
The 2021 ICUDDR Virtual Conference- Call for Proposals
The 2021 ICUDDR Virtual Conference will be held July 20 & 21, 2021. At this time, we are seeking proposals for this online event. Deadline is February 26, 2021.
Call for Proposals
ICUDDR is soliciting proposals for presentations at our...
Use of Technology in Psychosocial Treatment for Methamphetamine Use
This webinar describes how telephone, mHealth (text-messaging and apps), and computer-based interventions are used in the treatment of methamphetamine use. Key elements of the webinar include
- the research supporting each modality
- sug...
Modern psychiatry challenges of the XXI century
This year on November 25-27, the VIII International Scientific and Practical Conference "Psychiatry of the XXI Century: Global Impact on Modern Society and New Practices on the Ground" was held, co-organized by the Institute of Psychiatry...
Principles of Care for Young Adults With Substance Use Disorders
Researchers from the Grayken Center for Addiction at Boston Medical Center have published a series of articles in the Pediatrics journal addressing the six principles of care for young adults with substance use disorders.
The aim of the...
Overcoming Stigma Through Language: A Primer
Stigma is a significant barrier to wellness and good health for people who use substances.
The goal of this primer is to facilitate conversations and increase awareness of the stigma surrounding people who use substances, their support...
Webinar | Media-Based Persuasive Prevention
On 26th January, ISSUP Global supported a Webinar on the topic of the Role of Persuasion in Media-based Substance Prevention, with presentations from the Claremont Graduate University Media-Based Prevention Science Certificate Program Trainees, 2018-Present.
Research Society on Marijuana 2020 Virtual Poster Session Presentations
Each year the Research Society on Marijuana hold a poster session as part of their annual meeting.
The posters provide an excellent visual overview of the latest research on marijuana.
You can find all of the posters from the 2020 RSMj...
An Outcome Evaluation of Drug Treatment in Afghanistan
The results of the Afghanistan drug abuse treatment evaluation show positive change in illegal drug use and criminal behaviour.
EMCDDA Technical Report on New Psychoactive Substance
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...